Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Tong

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2018
Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant CancersCarl M Gay, Pan Tong, Robert J Cardnell, et al.
Molecular Cancer Research : MCR|September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple CancersKavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2Robert J G Cardnell, Carmen Behrens, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR InhibitionVaishnavi Sambandam, Mitchell J Frederick, Li Shen, et al.
Cancer Letters|January 28, 2017
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitorsMing Zhang, Ratnakar Singh, Shaohua Peng, et al.
Oncotarget|July 8, 2016
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutationsYuehong Wang, Ratnakar Singh, Liguang Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific deathThai H Ho, Payal Kapur, Richard W Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.
The Journal of Biological Chemistry|September 5, 2021
Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancersJayanthi P Gudikote, Tina Cascone, Alissa Poteete, et al.
Cancer Research|November 8, 2018
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione HomeostasisXiang Yan, Xiaoshan Zhang, Li Wang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2018
Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant CancersCarl M Gay, Pan Tong, Robert J Cardnell, et al.
Molecular Cancer Research : MCR|September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple CancersKavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2Robert J G Cardnell, Carmen Behrens, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR InhibitionVaishnavi Sambandam, Mitchell J Frederick, Li Shen, et al.
Cancer Letters|January 28, 2017
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitorsMing Zhang, Ratnakar Singh, Shaohua Peng, et al.
Oncotarget|July 8, 2016
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutationsYuehong Wang, Ratnakar Singh, Liguang Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific deathThai H Ho, Payal Kapur, Richard W Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.
The Journal of Biological Chemistry|September 5, 2021
Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancersJayanthi P Gudikote, Tina Cascone, Alissa Poteete, et al.
Cancer Research|November 8, 2018
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione HomeostasisXiang Yan, Xiaoshan Zhang, Li Wang, et al.
Pageof 6